Publications

1.  K. M. Hosny, O. A. A. Ahmed, R. T. Al-Abdali. Enteric-coated alendronate sodium nanoliposomes: a novel formula to overcome barriers for the treatment of osteoporosis. Expert Opin. Drug Deliv, 10(6):741-746 (2013).
2. K. M. El-Say, A. M. El-Helw, O. A. A. Ahmed, K. M. Hosny, T. A. Ahmed, Novel Controlled Release of Antihypertensive Drug: Preparation, In-Vitro and In-Vivo Evaluation, African J. Pharm. Pharmacol, 6 (32): (2013)
3.  A. F. AbdelWahab, A. K. Hussein, K. A. Khaled and O. A. A. Ahmed. Meloxicam Depot Parenteral Bio-Degradable Microspheres: Preparation, Characterization and In-Vivo Evaluation. Int. J. Pharm. Sci. Rev. Res, Vol. 21 (2), p38-45 (2013)
4.   A. I. Mohamed , M. I. A. EL-Assal, M. A. Kassem, I.S. Blagbrough and  O. A.A. Ahmed. Role of PLGA-Nanoparticles Formulation to Improve Drug Radioprotective Activity in Gamma-Irradiated Mice. Lat. Am. J. Pharm. 32(6): In PRESS (2013)
5. O. A. A. Ahmed, S. M Badr-Eldin and T. A. Ahmed. Kinetic study of the in vitro release and stability of theophylline floating beads. Int. J. Pharm. Pharm Sci., 5 (1): 179-184 (2013)
6.  I. S. Blagbrough, A. A. Metwally and O. A. A. Ahmed. Polyamine-Based Agents for Gene and siRNA Transfer. In P. Woster and R. Casero, Jr (eds) Polyamine Drug Discovery. RSC Drug Discovery Series No.17, Royal Society of Chemistry, 2012, pp 206-237. ISBN: 978-1-84973-190-4.
7. A. K. Hussein, M. A. Ibrahim, M. A. Amin, O. A. A. Ahmed and M. I. Afouna. Improved in vitro dissolution parameters and in vivo hypolipidimic efficiency of atorvastatin calcium through the formation of hydrophilic inclusion complex with cyclodextrins. DRUG DEV. RES., 72: 1-12 (2011)
8. A. I. Mohamed, M. I. Abdel-Tawab, O A. A. Ahmed, M. A. Kassem. Hydrophilic drug-loaded PLGA nanoparticles: systemic study of particle size and drug entrapment efficiency. B-FOPCU, 48 (1): A17-A37 (2010)
9. A. I. Mohamed, M. I. Abdel-Tawab, O A. A. Ahmed, M. A. Kassem. The role of drug-polymer interactions on the release of water-soluble drugs from biodegradable polymer matrix. Bull. Fac. Pharm. Cairo Univ., 47(1): 127-150 (2009)
10. H. M. Ghonaim, O A. A. Ahmed, C. Pourzand and I. S.  Blagbrough. Varying the Chain Length in N4,N9-Diacyl Spermines: Non-Viral Lipopolyamine Vectors for Efficient Plasmid DNA Formulation. Mol. Pharm. 5(6): 1111-1121 (2008)
11. O. A. A. Ahmed, C. Pourzand, and I. S. Blagbrough. Varying the unsaturation in N4,N9-dioctadecanoyl spermines: nonviral lipopolyamine vectors for more efficient plasmid DNA formulation. Pharm. Res. 23:31-40 (2006).
12. O. A. A. Ahmed, N. Adjimatera, C. Pourzand, and I. S. Blagbrough. N4,N9-Dioleoyl spermine is a novel nonviral lipopolyamine vector for plasmid DNA formulation. Pharm. Res. 22:972-980 (2005).
13. I. S. Blagbrough, N. Adjimatera, O. A. A. Ahmed, A. P. Neal, and C. Pourzand. Spermine and lipopolyamines as gene delivery agents. In D. J. Beadle, I. R. Mellor, and P. N. R. Usherwood (eds), Neurotox '03:  Neurotoxicological targets from functional genomics and proteomics, SCI, London, 2004, pp. 147-159. ISBN 10: 0901001864 / 0-901001-86-4 -ISBN 13: 9780901001863
14. S. H. Khidr, S. I. Abd El-Rahman, E. M. Fettoh, and O. A. A. Ahmed. Preparation and In-Vitro Evaluation of Floating Sustained-Release Captopril Tablets and Capsules. Bull. Pharm. Sci. Assiut University 23:85-90 (2000).